Sun Nuclear Broadens MRgRT QA Portfolio with Release of New Daily QA™-MR

MELBOURNE, Fla., Nov. 6, 2019 /PRNewswire/ — Sun Nuclear has announced the release of the Daily QA™-MR, the world’s first daily array for MR-Guided Radiation Therapy (MRgRT).

The new Daily QA-MR is built specifically to accommodate MR environments and performs three simultaneous beam quality checks — output, transverse symmetry and axial symmetry — for faster daily QA in the presence of magnetic fields up to 1.5T.

Leadership in MRgRT Patient & Machine QA
Sun Nuclear was first to market with dedicated MRgRT QA devices, enabling the clinical adoption of MRgRT systems worldwide. To date, more than 50 ArcCHECK-MR devices are already in use worldwide, making it the go-to solution for MR-guided patient QA. In addition, over 50 IC PROFILER-MR systems have been delivered to both of the leading MR-linac providers, and clinicians, to test, commission and perform QA on MRgRT systems. The Daily QA-MR is the next logical step in extending Sun Nuclear’s leadership in safe, efficient and effective MR-guided RT QA.

MRgRT QA Clinical Experience
On November 7, 2019, Sun Nuclear is pleased to offer a webinar presentation from an esteemed clinical user on experience using ArcCHECK-MR and IC PROFILER-MR in support of commissioning and routine quality assurance, and initial experience with Daily QA-MR. Kathryn Mittauer, Ph.D., Medical Physicist, will present “Commissioning and QA of an MR-guided Online Adaptive Program.” Registration is open for clinicians interested in attending the presentation.

“QA solutions that address the unique challenges of MRgRT are paramount to further adoption of and access to this promising modality,” notes Jeff Simon, CEO of Sun Nuclear. “At Sun Nuclear, we have always strived to ease technology adoption, and we are proud to provide MR QA solutions that offer the same level of efficiency and quality our customers have come to expect from our leading non-MR product lines.”

Visit sunnuclear.com to learn more about Sun Nuclear’s MRgRT QA solutions, including MICRO+™-MR lasers and Solid Water® HE.

About Sun Nuclear Corporation
Sun Nuclear provides innovative solutions for Radiation Therapy, Diagnostic Imaging and Patient Alignment. Our mission is to enable healthier lives by improving the detection and treatment of cancer. More than 5,000 cancer centers worldwide rely on us for independent, integrated Quality Management. With a focus on ongoing support, we aim to ease technology adoption, enhance workflows and improve outcomes – so that healthcare providers can achieve real results for Patient Safety. Visit us: sunnuclear.com. Follow us: @sunnuclear.

For additional information, please contact:
Kevin O’Malley, Sun Nuclear Corporation, (321) 259 6862 x1238, kevinomalley@sunnuclear.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/sun-nuclear-broadens-mrgrt-qa-portfolio-with-release-of-new-daily-qa-mr-300952975.html

SOURCE Sun Nuclear Corporation

user

Recent Posts

Cenegenics Improves Operational Efficiency with Domo

SILICON SLOPES, Utah--(BUSINESS WIRE)--Domo (Nasdaq: DOMO) announced today that Cenegenics, a leader in the performance…

3 hours ago

Lophos Holdings Inc. Announces the Completion of Securities Purchase Agreement with ThreeD Capital Inc.

Vancouver, British Columbia--(Newsfile Corp. - June 20, 2024) - Lophos Holdings Inc. (CSE: MESC) ("Lophos"…

3 hours ago

Pearl Health CEO Michael Kopko recognized as an EY Entrepreneur Of The Year® 2024 New York Award Winner

NEW YORK, June 20, 2024 /PRNewswire/ -- Ernst & Young LLP (EY US) today announced…

3 hours ago

ProviderTrust Named Top Place to Work by Modern Healthcare and The Tennessean Top Workplaces

NASHVILLE, Tenn., June 20, 2024 /PRNewswire/ -- ProviderTrust was recently selected by Modern Healthcare as one…

3 hours ago

Registration Opens for DeviceTalks West 2024

Why Did You Get into MedTech? Join us at DeviceTalks West to Learn from other…

6 hours ago

Gemina Laboratories Commences Trading on the OTCQB Market in the United States

Gemina Laboratories (OTCQB: GLABF), (CSE: GLAB), (FRA: 817) expands investor reach to U.S. by posting…

6 hours ago